Bfsg, LLC Pfizer Inc Transaction History

Bfsg, LLC

$838 Million
Q4 2024

A detailed history of Bfsg, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Bfsg, LLC holds 182,195 shares of PFE stock, worth $4.87 Million. This represents 0.58% of its overall portfolio holdings.

Number of Shares

182,195

Previous 273,172 33.3%

Holding current value

$4.87 Million

Previous $7.91 Million 38.86%

% of portfolio

0.58%

Previous 0.94%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 31, 2025	SELL	$24.8 - $30.19 $2.26 Million - $2.75 Million	-90,977 Reduced 33.3%	182,195 $4.83 Million
Q3 2024 Oct 16, 2024	SELL	$27.7 - $31.39 $59,361 - $67,268	-2,143 Reduced 0.78%	273,172 $7.91 Million
Q2 2024 Jul 29, 2024	BUY	$25.26 - $29.6 $3.02 Million - $3.54 Million	119,447 Added 76.63%	275,315 $7.7 Million
Q1 2024 Apr 23, 2024	SELL	$25.89 - $29.73 $113,501 - $130,336	-4,384 Reduced 2.74%	155,868 $4.33 Million
Q4 2023 Feb 01, 2024	SELL	$26.13 - $33.94 $223,463 - $290,254	-8,552 Reduced 5.07%	160,252 $4.61 Million
Q3 2023 Oct 20, 2023	BUY	$32.09 - $37.51 $302,993 - $354,169	9,442 Added 5.92%	168,804 $5.6 Million
Q2 2023 Aug 07, 2023	SELL	$36.12 - $41.79 $70,650 - $81,741	-1,956 Reduced 1.21%	159,362 $5.85 Million
Q1 2023 May 10, 2023	BUY	$39.39 - $51.28 $3.46 Million - $4.51 Million	87,922 Added 119.79%	161,318 $6.58 Million
Q4 2022 Feb 01, 2023	BUY	$41.75 - $54.5 $37,408 - $48,832	896 Added 1.24%	73,396 $3.76 Million
Q3 2022 Nov 07, 2022	SELL	$43.76 - $53.42 $26,343 - $32,158	-602 Reduced 0.82%	72,500 $3.17 Million
Q2 2022 Aug 04, 2022	SELL	$46.53 - $55.17 $14,238 - $16,882	-306 Reduced 0.42%	73,102 $3.83 Million
Q1 2022 May 04, 2022	SELL	$45.75 - $56.69 $259,494 - $321,545	-5,672 Reduced 7.17%	73,408 $3.8 Million
Q4 2021 Jan 24, 2022	SELL	$41.32 - $61.25 $208,748 - $309,435	-5,052 Reduced 6.0%	79,080 $4.67 Million
Q3 2021 Nov 03, 2021	SELL	$39.25 - $50.42 $36,267 - $46,588	-924 Reduced 1.09%	84,132 $3.62 Million
Q2 2021 Jul 29, 2021	SELL	$35.91 - $40.68 $104,067 - $117,890	-2,898 Reduced 3.29%	85,056 $3.33 Million
Q1 2021 Apr 26, 2021	SELL	$33.49 - $37.77 $1.14 Million - $1.29 Million	-34,085 Reduced 27.93%	87,954 $3.19 Million
Q4 2020 Jan 26, 2021	BUY	$33.47 - $42.56 $367,534 - $467,351	10,981 Added 9.89%	122,039 $4.49 Million
Q3 2020 Nov 04, 2020	BUY	$31.75 - $37.25 $15,113 - $17,731	476 Added 0.43%	111,058 $4.08 Million
Q2 2020 Jul 22, 2020	BUY	$30.12 - $36.54 $25,240 - $30,620	838 Added 0.76%	110,582 $3.62 Million
Q1 2020 Apr 27, 2020	BUY	$27.03 - $38.62 $220,024 - $314,366	8,140 Added 8.01%	109,744 $3.58 Million
Q4 2019 Jan 29, 2020	BUY	$32.92 - $37.36 $222,242 - $252,217	6,751 Added 7.12%	101,604 $3.98 Million
Q3 2019 Oct 25, 2019	BUY	$32.49 - $42.13 $1.15 Million - $1.49 Million	35,297 Added 59.27%	94,853 $3.36 Million
Q2 2019 Jul 30, 2019	SELL	$36.98 - $41.52 $14,459 - $16,234	-391 Reduced 0.65%	59,556 $2.58 Million
Q1 2019 Apr 18, 2019	SELL	$37.5 - $41.2 $1,875 - $2,060	-50 Reduced 0.08%	59,947 $2.55 Million
Q4 2018 Jan 24, 2019	BUY	$38.47 - $43.86 $1,808 - $2,061	47 Added 0.08%	59,997 $2.62 Million
Q3 2018 Oct 18, 2018	SELL	$34.47 - $41.81 $34,952 - $42,395	-1,014 Reduced 1.66%	59,950 $2.64 Million
Q2 2018 Jul 31, 2018	SELL	$32.98 - $35.16 $14,577 - $15,540	-442 Reduced 0.72%	60,964 $2.21 Million
Q1 2018 May 08, 2018	SELL	$31.91 - $37.02 $63 - $74	-2 Reduced -0.0%	61,406 $2.18 Million
Q4 2017 Jan 23, 2018	SELL	$33.26 - $35.29 $23,614 - $25,055	-710 Reduced 1.14%	61,408 $2.22 Million
Q3 2017 Oct 12, 2017	SELL	$31.0 - $34.15 $35,340 - $38,931	-1,140 Reduced 1.8%	62,118 $2.22 Million
Q2 2017 Aug 10, 2017	BUY	N/A	63,258	63,258 $2.13 Million

Others Institutions Holding PFE

# of Institutions

3,357

Shares Held

3.69B

Call Options Held

106M

Put Options Held

123M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bfsg, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bfsg, LLC with notifications on news.

Account